Registration is now open for the Aesthetics Conference and Exhibition 2017, encompassing a wide range of clinical and business agendas covering the latest in medical aesthetics
Global pharmaceutical company Allergan has announced it will purchase clinical-stage biotechnology company Vitae Pharmaceuticals.
Bioidentical hormone specialist Dr Marion Gluck will be running more training courses in London to help practitioners understand the role and benefits of hormones.
On June 16-19 practitioners from across the UK and abroad gathered at the Queen Elizabeth II centre in central London for four days to discover the latest advancements in antiageing.
The annual Aesthetics Conference and Exhibition (ACE) will take place at the Business Design Centre in Islington, London, on March 31-April 1 next year.
Practitioners had the opportunity to refresh and update their skills, learn from international experts and network with their peers at the British Association of Sclerotherapists (BAS) Annual Meeting on April 28 at the Ark Conference Centre, Basingstoke, Hampshire.
Global US biopharmaceutical company Pfizer has announced it will purchase Anacor in a US $5.2 billion deal.
Laser and light-based aesthetic treatment and manufacturing company Cynosure will discuss the changes in training requirements at a regulation seminar.
Scientists from the US have developed an elastic, wearable cross-linked polymer layer (XPL) that aims to mimic the properties of normal, youthful skin.
Dr Simon Ravichandran outlines the highlights of the Association of Scottish Aesthetic Practitioners meeting in Glasgow